Internal Server Error

About TPTF

TPTF is a venture capital firm founded in 2014. It is primarily based out of Taipei, Taiwan. As of Oct 2024, TPTF has invested in 16 companies. It primarily invests in Seed round in Indonesia based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of Rey Overall, TPTF portfolio has seen 5 IPOs and 4 acquisitions including key companies like Crown Bioscience, Quanergy Com and Applied BioCode. A lot of funds co-invest with TPTF, with names like MDI Ventures sharing a substantial percentage of its portfolio. TPTF has team of 11 people including 2 partners.
Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series C & 2 more
Portfolio Acquisitions

TPTF's List of Top Investments

TPTF has a portfolio of 16 companies. Their most notable investments are in Rey and Kata.Their portfolio spans across United States, Indonesia, Taiwan and 1 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 12 other sectors, across stages such as Seed, Series C  and 2 more. Here is the list of top investments by TPTF:
Crown Bioscience develops drugs for cancer and CVMD (Cardiovascular and Metabolic Diseases). The company’s proprietary platform includes HuPrime that is a patient-derived xenograft (PDX) models which can be used for efficacy testing. It also offers oncology services, such as oncology databases, ex vivo services, human surrogate trials, in vitro and in vivo services, preclinical models (PDX, Humanized and Murine efficacy/PD) for CAR-T Therapy Evaluation (immuno-oncology) etc., CrownBio also has a variety of rodent and mouse models for the development of drugs for CVMD. The company also offers products, such as antibodies for in vivo and in-vitro studies, tissues for CVMD research, tumor samples for Oncology R&D, cytokines and growth factors for use in basic and preclinical research, recombinant proteins and cell lines for biological studies, immune checkpoint antibodies and tumor tissue microarrays. CrownBio has strategic partnerships with Xstrahl, a designer, and manufacturer of X-Ray solutions for radiation biology research and Horizon Discovery, a provider of advanced research tools and services for the development of personalized medicines. CrownBio acquired PreClinOmics, an in vivo preclinical company specializing in CVMD and renal disease research. The company has spun-off CBT pharmacueticals, an emerging life science oncology company.

Key facts about Crown Bioscience

Provider of AI-driven LiDAR sensing solutions. It offers hardware and software solutions for LiDAR sensing. It also provides various products including mechanical lidar sensors, solid-state lidar sensors, and perception software. Its features include real-time analysis for people counting, object detection, classification, and tracking. It has applications in mapping, smart cities, industrial automation, and social distancing.

Key facts about Quanergy Com

Developer of assay testing kits and instruments for in vitro diagnostics, research, and other industrial applications. The company develops, manufactures, and commercializes multiplex diagnostic testing products that inlcudes testing assays that detect pathogens for gastrointestinal infections, respiratory infections, and other high-value diseases. Also, it offers a BioCode MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP).

Key facts about Applied BioCode

  • Founded Year: 2008
  • Location: Santa Fe Springs (United States)
  • Stage: Public
  • Total Funding till date: $20.3M
  • Employee Count: 75 as on Aug 31, 2026
  • Investors: ID Ventures America, TPTF and 4 Others
  • Latest Funding Round: Series A, Apr 07, 2016, $*****
  • Highlight: Public

4. Kata

Provider of AI and SaaS-based conversational platform for business. It offers a dialogue engine that allows brands to operate a chatbot on various platforms such as LINE, Facebook, Twitter, BBM, and Telegram. It includes product marketing, sales transaction, and market research.

Key facts about Kata

Platform utilizing genomics and machine learning to research and develop novel materials. It is a biotechnology company that specializes in designing and producing molecules, microbes, and materials for diverse end markets through the use of genomics and machine learning. The company partners with nature to create innovative solutions across various industries. Their products cater to diverse applications, including crop protection, food preservation, and animal nutrition.

Key facts about Zymergen

TPTF's Investments by Stage

TPTF has made 2 investments in Seed stage with an average round size of $2M, 2 investments in Series C stage with an average round size of $230M, 1 investment in Series A stage with an average round size of $3.5M and 1 investment in Series B stage with an average round size of $23.5M.
Here are TPTF's investments by stage:
Stage of entry
No. of Investments
Seed
2
Series C
2
Series A
1
Series B
1
Breakdown of TPTF's investments by stage of entrySeed (2)Series C (2)
Note: We have considered here, only first round of investments

TPTF's Investments by Sector

TPTF has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, High Tech, Sustainability Tech and Business Services. Notably, it has invested in 14 Enterprise (B2B) companies, 12 Tech companies, 7 Software companies and at least 3 companies focusing on Saas.
Here are TPTF's investments by sector:
Sector
No. of Investments
Enterprise Applications
3
HealthTech
2
High Tech
2
Sustainability Tech
2
Business Services
1
Others
4
Breakdown of TPTF's investments by sectorsEnterprise Applic... (3)HealthTech (2)
Note: We have considered here, only first round of investments

TPTF's Investments by Geography

TPTF has made most investments in Indonesia (3), followed by United States where it has made 2 investments.
Here are TPTF's investments by geography:
Country
No. of Investments
Indonesia
3
United States
2
China
1
Breakdown of TPTF's investments by countriesIndonesia (3)United States (2)
Note: We have considered here, only first round of investments

TPTF's recent investments

TPTF has not made any investment in 2026 so far.
Here are the most recent investments by TPTF:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Oct 01, 2024
Indonesia
Seed
7619
Jul 06, 2022
Indonesia
Seed
8310
Sep 13, 2021
Indonesia
Seed
5364
-
Jun 04, 2021
Indonesia
Seed
3541
Nov 25, 2020
Indonesia
Series B
4233

IPOs and Publicly Listed companies in TPTF's Portfolio

5 of TPTF's portfolio companies have become public. Googol Technology got listed on the Shenzhen Stock Exchange (SZSE), in Aug 2023 at marketcap of $659M and MegaPro Biomedical got listed on the Taipei Stock Exchange (TT).
Here are TPTF's portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Aug 15, 2023
-
-
4120
Oct 19, 2021
-
-
3399
Mar 19, 2021
Jul 19, 2019
Series C
9258
Jun 09, 2020
-
-
1990
Apr 24, 2020
-
-
1303

Acquired companies in TPTF's Portfolio

4 companies from TPTF's portfolio have been acquired. The most recent acquisition was Crown Bioscience in Nov 2025 by Aidikang Medical Laboratory Center for $*****.
Here are TPTF's portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Nov 13, 2025
-
-
4293
Aug 23, 2023
-
-
8187
Jul 25, 2022
Dec 17, 2018
Series C
4800
Jul 08, 2020
-
-
8326

Team profile of TPTF

TPTF has a team of 11 members including 2 Partners, 2 Venture Partners and 1 Principal located in Taiwan, China and 1 more location. TPTF's team does not sit on the board of any company as of now.
Here is a list of top team members in TPTF:
Name
Designation
Location
Board Memberships
Contact Details
Partner
United States
-
-
Partner
Taiwan
-
Venture Partner
Hong Kong
-
Venture Partner
-
-
Principal
Taipei
-

Co-investors of TPTF

Over the past 10 years, 53 investors have co-invested in TPTF's portfolio companies. This includes funds and angels.

Recent News related to TPTF

Prixa Raises $3M in FundingFinSMEsJun 07, 2021Prixa, MDI Ventures, TPTF, Siloam Hospitals and 6 others
View all news related to TPTF

FAQs about TPTF

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford